Recon: Moderna begins a Phase 2 hybrid trial for Omicron, while the FDA expands the use of CRLs for breakthrough medications.
⬆Links to an external web page: click to leave
Up-vote or down-vote this result.
a little different search engine
You've arrived at result 2419688
Links to an external web page: click to leave
Up-vote or down-vote this result.